Post-tuberculosis treatment paradoxical reactions
Open Access
- 2 July 2024
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 52 (5) , 2083-2095
Abstract
Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with recurrent signs or symptoms of TB after cure or completion of prior treatment needs to be differentiated between microbiological relapse and a paradoxical reaction. We searched all published literature on post-treatment PR, and present a synthesis of 30 studies, focusing on the epidemiology, diagnosis and management of this phenomenon. We report an additional case vignette. The majority of studies were of lymph node TB (LN-TB), followed by central nervous system TB (CNS-TB). A total of 112 confirmed and 42 possible post-treatment PR cases were reported. The incidence ranged between 3 and 14% in LN-TB and was more frequent than relapses, and between 0 and 2% in all TB. We found four reports of pulmonary or pleural TB post-treatment PR cases. The incidence did not differ by length of treatment, but was associated with younger age at initial diagnosis, and having had a PR (later) during treatment. Post-treatment PR developed mainly within the first 6 months after the end of TB treatment but has been reported many years later (longest report 10 years). The mainstays of diagnosis and management are negative mycobacterial cultures and anti-inflammatory treatment, respectively. Due to the favourable prognosis in LN-TB recurrent symptoms, a short period of observation is warranted to assess for spontaneous regression. In CNS-TB with recurrent symptoms, immediate investigation and anti-inflammatory treatment with the possibility of TB retreatment should be undertaken.Keywords
This publication has 59 references indexed in Scilit:
- The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature reviewEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- Paradoxical manifestations during tuberculous meningitis treatment among HIV-negative patients: a retrospective descriptive study and literature reviewNeurological Sciences, 2021
- Determinants of lymph node resolution in patients of tubercular lymphadenitis treated with anti tuberculous chemotherapy: A hospital based longitudinal studyIndian Journal of Tuberculosis, 2020
- Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patientsInfection, 2012
- Prolonged Paradoxical Reaction of Tuberculosis in an HIV-Infected Patient after Initiation of Highly Active Antiretroviral TherapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Clinical Spectrum of Paradoxical Deterioration During Antituberculosis Therapy in Non-HIV-Infected PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- The treatment of superficial tuberculous lymphadenitisTubercle, 1990
- Short course chemotherapy for lymph node tuberculosis: final report at 5 yearsRespiratory Medicine, 1988
- A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis Final report: Results during the 36 months after the end of chemotherapy and beyondRespiratory Medicine, 1984
- Lymph node tuberculosis: A comparison of treatments 18 months after completion of chemotherapyTubercle, 1979